Jump to Content
Jump to Main Navigation
HOME
BROWSE
SUBJECTS
CLINICAL RESOURCES
DRUG INFORMATION
EDUCATION AND TRAINING
PHARMACY PRACTICE
CAREER DEVELOPMENT
AJHP
DRUG INFORMATION
PROFESSIONAL DEVELOPMENT
Sign in
Sign up
SEARCH
Advanced Search
Help
Sign in
Sign up
HOME
BROWSE
SUBJECTS
CLINICAL RESOURCES
DRUG INFORMATION
EDUCATION AND TRAINING
PHARMACY PRACTICE
CAREER DEVELOPMENT
AJHP
DRUG INFORMATION
PROFESSIONAL DEVELOPMENT
SEARCH
Advanced Search
Help
Search within results
Search within results
Filter
Filter
Refine by Subjects
Clinical Resources
(1,314)
Drug Information
(932)
Educational & Training
(244)
Pharmacy Practice
(19)
Refine by Access
All content
Content accessible to me
Refine by Type
Books
(20)
Chapters
(1,294)
Submit
Refine by Date
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2009
2008
2002
—
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2009
2008
2002
Submit
Print
Save
Email this link
Share Link
Copy this link, or click below to email it to a friend
Email this link
or copy the link directly:
https://publications.ashp.org/collection/ClinicalResources?access=all&page=7&pageSize=50&sort=datedescending
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
Browse
You are looking at
301
-
350
of
1,314
items for
Refine by Access: All content
x
Clear All
Items per page:
10
20
50
Sort by:
Title A - Z
Title Z - A
Author A - Z
Author Z - A
Date - Old to Recent
Date - Recent to Old
Page:
1
2
3
4
5
6
7
8
9
10
11
12
...
Restricted access
Dapsone Suspension 2 mg/mL—Formulation 1
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Dapsone Suspension 2 mg/mL—Formulation 2
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Dapsone Syrup 2 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Free access
1 Definitions and Concepts
Karen J. Tietze
Chapter
In
Basic Skills in Interpreting Laboratory Data
Published (Print):
01 Jan 2022
Restricted access
Dexamethasone Suspension 1 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Diazoxide Suspension 10 mg/mL—Formulation 1
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Diazoxide Suspension 10 mg/mL—Formulation 2
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Diclofenac Sodium Suspension 5 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
13 DIGOXIN
Robert J. DiDomenico and II Robert L. Page
Chapter
In
Clinical Pharmacokinetics
Published (Print):
01 Jan 2022
Restricted access
CH 1.7 Digoxin
John E. Murphy
Chapter
In
Clinical Pharmacokinetics Workbook
Published (Print):
01 Jan 2022
Restricted access
CH 2.7 Digoxin
John E. Murphy
Chapter
In
Clinical Pharmacokinetics Workbook
Published (Print):
01 Jan 2022
Restricted access
Diltiazem Hydrochloride Suspension 12 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Diltiazem Suspension 12 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Dipyridamole Suspension 10 mg/mL—Formulation 1
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Dipyridamole Suspension 10 mg/mL—Formulation 2
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Disopyramide Syrup 1 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Disopyramide Syrup 10 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Dolasetron Mesylate Suspension 10 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
6 DRUG DOSING IN PEDIATRIC PATIENTS
Vinita B. Pai and Milap C. Nahata
Chapter
In
Clinical Pharmacokinetics
Published (Print):
01 Jan 2022
Restricted access
22 Drug Screens and Toxicological Tests
Peter A. Chyka
Chapter
In
Basic Skills in Interpreting Laboratory Data
Published (Print):
01 Jan 2022
Restricted access
11 Electrolytes, Other Minerals, and Trace Elements
Lingtak-Neander Chan and Jasmine S. Mangrum
Chapter
In
Basic Skills in Interpreting Laboratory Data
Published (Print):
01 Jan 2022
Restricted access
Enalapril Maleate Suspension 0.1 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Enalapril Maleate Suspension 1 mg/mL—Formulation 1
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Enalapril Maleate Suspension 1 mg/mL—Formulation 2
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Enalapril Maleate Suspension 1 mg/mL—Formulation 3
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
9 Endocrine Disorders
Eva Vivian
Chapter
In
Basic Skills in Interpreting Laboratory Data
Published (Print):
01 Jan 2022
Restricted access
Erlotinib Suspension 10 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Eslicarbazepine Acetate Suspension 40 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
CH 1.3 Estimating Kidney Function
John E. Murphy
Chapter
In
Clinical Pharmacokinetics Workbook
Published (Print):
01 Jan 2022
Restricted access
CH 2.3 Estimating Kidney Function
John E. Murphy
Chapter
In
Clinical Pharmacokinetics Workbook
Published (Print):
01 Jan 2022
Restricted access
Ethacrynic Acid Solution 1 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
14 ETHOSUXIMIDE
Jacquelyn L. Bainbridge, Pei Shieen Wong, Sarah N. Rajkovic, and Grace S. Chin
Chapter
In
Clinical Pharmacokinetics
Published (Print):
01 Jan 2022
Restricted access
Etoposide Solution 10 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Extemporaneous Formulations
for Pediatric, Geriatric, and Special Needs Patients
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Book
Published (Print):
Jan 2022
Restricted access
Famotidine Suspension 8 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Famotidine Syrup 8 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Flecainide Acetate Suspension 20 mg/mL—Formulation 1*
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Flecainide Acetate Suspension 20 mg/mL—Formulation 2
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Fluconazole Solution 1 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Flucytosine Suspension 10 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Flucytosine Suspension 50 mg/mL*
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Fluoxetine Hydrochloride Syrup 1 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Fluoxetine Hydrochloride Syrup 2 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Furosemide Suspension 2 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Furosemide Suspension 9.6 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Gabapentin Suspension 100 mg/mL—Formulation 1
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Gabapentin Suspension 100 mg/mL—Formulation 2
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Gabapentin Suspension 50 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Ganciclovir Intravitreous Solution 20 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Free access
CH 1.1 General Pharmacokinetic Applications
John E. Murphy
Chapter
In
Clinical Pharmacokinetics Workbook
Published (Print):
01 Jan 2022
Items per page:
10
20
50
Sort by:
Title A - Z
Title Z - A
Author A - Z
Author Z - A
Date - Old to Recent
Date - Recent to Old
Page:
1
2
3
4
5
6
7
8
9
10
11
12
...
[44.200.145.223]
44.200.145.223
